XenoTherapeutics Overview
- Founded
- 2016

- Status
- Private
- Employees
- 10

- Latest Deal Type
- Grant
- Investors
- 3
XenoTherapeutics General Information
Description
Operator of a gene therapy company intended to develop personalized cells, tissues, and organs for transplantation. The company's first product is derived from genetically engineered, immune-corrected pigs, enabling victims with severe and extensive burns in Phase I clinical trial to access an affordable, safe and plentiful treatment whenever is necessary.
Contact Information
- PO Box 1362
- Londonderry, NH 03053
- United States
XenoTherapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Grant | Completed | Startup | ||||
2. Grant | 27-Jan-2017 | 0000 | Completed | Startup | ||
1. Grant | 19-May-2016 | Completed | Startup |
XenoTherapeutics Comparisons
Industry
000000
00000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialXenoTherapeutics Competitors (4)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
ITBMed | Venture Capital-Backed | Stockholm, Sweden | 00 | 0000 | 0000000000 0 | 0000 |
00000000 | Venture Capital-Backed | Cambridge, MA | 00 | 00000 | 00000000000 | 00000 |
000000 00000000000 | Formerly VC-backed | Silver Spring, MD | 000 | 00000 | 000000 - 000 | 00000 |
000000000 | Corporation |
XenoTherapeutics Executive Team (5)
XenoTherapeutics Board Members (3)
Name | Representing | Role | Since |
---|---|---|---|
Michael Yaremchuk | XenoTherapeutics | Trustee of Board | 000 0000 |
Paul Barrett | XenoTherapeutics | Chairman | 000 0000 |
XenoTherapeutics Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialXenoTherapeutics Investors (3)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
John Flatley Company | Corporation | 000 0000 | 000000 0 | ||
MassChallenge | Accelerator/Incubator | 000 0000 | 000000 0 | ||
Columbia Technology Ventures | University | Minority | 000 0000 | 000000 0 |